(Q37770210)

22 August 2017

1 reference

title

Is it time for a change? The case for early application of unrelated allo-SCT for severe aplastic anemia (English)

1 reference

22 August 2017

G Meyers

1

1 reference

22 August 2017

R T Maziarz

series ordinal

2

1 reference

22 August 2017

language of work or name

English

0 references

publication date

5 July 2010

1 reference

Bone Marrow Transplantation

22 August 2017

published in

1 reference

22 August 2017

volume

45

1 reference

22 August 2017

issue

10

1 reference

22 August 2017

page(s)

1479-1488

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2010.134

22 August 2017

exact match

0 references

cites work

Allogeneic stem cell transplantation for aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Fludarabine, cyclophosphamide plus thymoglobulin conditioning regimen for unrelated bone marrow transplantation in severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

A fludarabine-based conditioning regimen for severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradiation, cyclophosphamide and Campath

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Fatal adenoviral and enteroviral infections and an Epstein-Barr virus positive large B-cell lymphoma after alemtuzumab treatment in a patient with refractory Sézary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Fatal adenovirus infection during alemtuzumab (anti-CD52 monoclonal antibody) treatment of a patient with fludarabine-refractory B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Umbilical-cord blood cell transplantation conditioned with a reduced intensity-regimen is a practical salvage therapy for severe aplastic anemia refractory to immunosuppressive therapy with antithymocyte globulin/ciclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Guidelines for the diagnosis and management of aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Aplastic anemia: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Double cord blood transplantation in patients with high risk bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Sustained and stable hematopoietic donor-recipient mixed chimerism after unrelated cord blood transplantation for adult patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Umbilical cord blood transplant for adult patients with severe aplastic anemia using anti-lymphocyte globulin and cyclophosphamide as conditioning therapy

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Cord blood transplantation from HLA-mismatched unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.134

7 January 2021

Identifiers

DOI

10.1038/BMT.2010.134

1 reference

22 August 2017

1 reference